Drug information for CHORIONIC GONADOTROPIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 10,000 UNITS/VIAL Prescription AP (Reference Drug) GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING 17016
2011-04-19 Letter
2011-04-18 Label
INJECTABLE; INJECTION 15,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING   "
INJECTABLE; INJECTION 2,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING   "
INJECTABLE; INJECTION 2,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING   "
INJECTABLE; INJECTION 20,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING   "
INJECTABLE; INJECTION 5,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin FERRING   "
INJECTABLE; INJECTION 10,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin BEL MAR 17054
INJECTABLE; INJECTION 5,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin BEL MAR   "
INJECTABLE; INJECTION 10,000 UNITS/VIAL Prescription AP (Reference Drug) GONADOTROPIN, CHORIONIC Chorionic Gonadotropin APP PHARMS 17067
2011-04-19 Letter
2011-04-18 Label
INJECTABLE; INJECTION 15,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin APP PHARMS   "
INJECTABLE; INJECTION 20,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin APP PHARMS   "
INJECTABLE; INJECTION 5,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin APP PHARMS   "
Injectable; Injection 5,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin QUAD PHARMS 89312
Injectable; Injection 5,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin QUAD PHARMS 89313
Injectable; Injection 10,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin QUAD PHARMS 89314
Injectable; Injection 10,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin QUAD PHARMS 89315
Injectable; Injection 20,000 UNITS/VIAL Discontinued   GONADOTROPIN, CHORIONIC Chorionic Gonadotropin QUAD PHARMS 89316

Drug Adverse Effects information for CHORIONIC GONADOTROPIN

Role code Indications Reaction # Reports
PS IN VITRO FERTILISATION HAEMATOCRIT DECREASED 3
PS IN VITRO FERTILISATION HAEMORRHAGIC OVARIAN CYST 3
PS IN VITRO FERTILISATION OVARIAN HYPERSTIMULATION SYNDROME 3
PS IN VITRO FERTILISATION OVARIAN RUPTURE 3
PS IN VITRO FERTILISATION OVARIAN TORSION 3
PS IN VITRO FERTILISATION SHOCK 3
PS IN VITRO FERTILISATION WHITE BLOOD CELL COUNT INCREASED 3
PS OVERWEIGHT ASTHENIA 1
PS OVERWEIGHT BLOOD GLUCOSE INCREASED 1
PS OVERWEIGHT DISTURBANCE IN ATTENTION 1
PS OVERWEIGHT HYPERSOMNIA 1
PS OVERWEIGHT IMPAIRED DRIVING ABILITY 1
PS OVERWEIGHT INSOMNIA 1
PS OVERWEIGHT THYROID DISORDER 1
PS OVERWEIGHT TREMOR 1
PS OVULATION INDUCTION ABORTION INDUCED 2
PS OVULATION INDUCTION ABORTION THREATENED 2
PS OVULATION INDUCTION ARTERIAL HAEMORRHAGE 1
PS OVULATION INDUCTION BENIGN HYDATIDIFORM MOLE 2
PS OVULATION INDUCTION BLOOD PRESSURE DECREASED 1
PS OVULATION INDUCTION HYPEREMESIS GRAVIDARUM 2
PS OVULATION INDUCTION OVARIAN ENLARGEMENT 2
PS OVULATION INDUCTION OVARIAN HYPERSTIMULATION SYNDROME 2
PS OVULATION INDUCTION OVARIAN RUPTURE 1
PS OVULATION INDUCTION OVARIAN TORSION 1
PS OVULATION INDUCTION TACHYCARDIA 1
PS OVULATION INDUCTION VAGINAL HAEMORRHAGE 2
PS PRODUCT USED FOR UNKNOWN INDICATION ABORTION INDUCED 1
PS PRODUCT USED FOR UNKNOWN INDICATION ABORTION SPONTANEOUS 2
PS PRODUCT USED FOR UNKNOWN INDICATION ABORTION THREATENED 1
PS PRODUCT USED FOR UNKNOWN INDICATION BENIGN HYDATIDIFORM MOLE 1
PS PRODUCT USED FOR UNKNOWN INDICATION HYPEREMESIS GRAVIDARUM 1
PS PRODUCT USED FOR UNKNOWN INDICATION OVARIAN ENLARGEMENT 1
PS PRODUCT USED FOR UNKNOWN INDICATION OVARIAN HYPERSTIMULATION SYNDROME 3
PS PRODUCT USED FOR UNKNOWN INDICATION VAGINAL HAEMORRHAGE 1
PS WEIGHT CONTROL DECREASED APPETITE 1
PS WEIGHT CONTROL VOMITING 1
PS WEIGHT DECREASED ABDOMINAL DISTENSION 1
PS WEIGHT DECREASED ALOPECIA 1
PS WEIGHT DECREASED EMOTIONAL DISORDER 1
SS IN VITRO FERTILISATION ABDOMINAL DISTENSION 6
SS IN VITRO FERTILISATION CAESAREAN SECTION 6
SS IN VITRO FERTILISATION CEPHALO-PELVIC DISPROPORTION 6
SS IN VITRO FERTILISATION CIRCULATORY FAILURE NEONATAL 6
SS IN VITRO FERTILISATION CONGENITAL HYDROCEPHALUS 6
SS IN VITRO FERTILISATION CRANIOPHARYNGIOMA 6
SS IN VITRO FERTILISATION CYSTOSARCOMA PHYLLODES 1
SS IN VITRO FERTILISATION DEATH NEONATAL 6
SS IN VITRO FERTILISATION FEEDING DISORDER NEONATAL 6
SS IN VITRO FERTILISATION FOETAL EXPOSURE DURING PREGNANCY 6
SS IN VITRO FERTILISATION HEPATOBLASTOMA 6
SS IN VITRO FERTILISATION NEONATAL RESPIRATORY FAILURE 6
SS IN VITRO FERTILISATION OVARIAN HYPERSTIMULATION SYNDROME 3
SS IN VITRO FERTILISATION TUMOUR NECROSIS 6
SS IN VITRO FERTILISATION URETERIC INJURY 3
SS OVULATION INDUCTION CYSTOSARCOMA PHYLLODES 4
SS OVULATION INDUCTION ECTOPIC PREGNANCY 4
SS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL DISTENSION 2
SS PRODUCT USED FOR UNKNOWN INDICATION CAESAREAN SECTION 2
SS PRODUCT USED FOR UNKNOWN INDICATION CEPHALO-PELVIC DISPROPORTION 2
SS PRODUCT USED FOR UNKNOWN INDICATION CIRCULATORY FAILURE NEONATAL 2
SS PRODUCT USED FOR UNKNOWN INDICATION CONGENITAL HYDROCEPHALUS 2
SS PRODUCT USED FOR UNKNOWN INDICATION CRANIOPHARYNGIOMA 2
SS PRODUCT USED FOR UNKNOWN INDICATION DEATH NEONATAL 2
SS PRODUCT USED FOR UNKNOWN INDICATION FEEDING DISORDER NEONATAL 2
SS PRODUCT USED FOR UNKNOWN INDICATION FOETAL EXPOSURE DURING PREGNANCY 2
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATOBLASTOMA 2
SS PRODUCT USED FOR UNKNOWN INDICATION NEONATAL RESPIRATORY FAILURE 2
SS PRODUCT USED FOR UNKNOWN INDICATION TUMOUR NECROSIS 2
C AMENORRHOEA ABORTION 3
C AMENORRHOEA TWIN PREGNANCY 3
C ANOVULATORY CYCLE ABORTION 2
C CONTRACEPTION DEEP VEIN THROMBOSIS 1
C CONTRACEPTION HAEMOGLOBINURIA 1
C CONTRACEPTION HEPATIC CYST 1
C CONTRACEPTION LUNG CONSOLIDATION 1
C CONTRACEPTION PREGNANCY TEST FALSE POSITIVE 1
C CONTRACEPTION PULMONARY EMBOLISM 1
C CONTRACEPTION PULMONARY INFARCTION 1
C CONTRACEPTION TACHYCARDIA 1
C CONTRACEPTION UNINTENDED PREGNANCY 2
C DECREASED APPETITE BREAST TENDERNESS 1
C DECREASED APPETITE DYSGEUSIA 1
C DECREASED APPETITE NAUSEA 1
C DECREASED APPETITE PAROSMIA 1
C IN VITRO FERTILISATION ABORTION SPONTANEOUS 2
C IN VITRO FERTILISATION DYSPNOEA 2
C IN VITRO FERTILISATION ERYTHEMA 1
C IN VITRO FERTILISATION GENITAL ERYTHEMA 1
C IN VITRO FERTILISATION GENITAL SWELLING 1
C IN VITRO FERTILISATION MATERNAL EXPOSURE DURING PREGNANCY 1
C IN VITRO FERTILISATION MATERNAL EXPOSURE TIMING UNSPECIFIED 1
C IN VITRO FERTILISATION OEDEMA 2
C IN VITRO FERTILISATION OVARIAN HYPERSTIMULATION SYNDROME 2
C IN VITRO FERTILISATION PRURITUS 1
C IN VITRO FERTILISATION PRURITUS GENITAL 1
C IN VITRO FERTILISATION SWELLING 1
C IN VITRO FERTILISATION TRISOMY 21 2
C JUVENILE ARTHRITIS CEPHALO-PELVIC DISPROPORTION 1
C JUVENILE ARTHRITIS OVULATION DISORDER 1
C OVULATION INDUCTION ASCITES 9
C OVULATION INDUCTION CYTOLYTIC HEPATITIS 6
C OVULATION INDUCTION EFFUSION 2
C OVULATION INDUCTION OVARIAN HYPERSTIMULATION SYNDROME 11
C OVULATION INDUCTION OVARIAN TORSION 2
C OVULATION INDUCTION PELVIC INFECTION 3
C OVULATION INDUCTION PREGNANCY 6
C OVULATION INDUCTION VOMITING 2
C POST COITAL CONTRACEPTION BREAST TENDERNESS 1
C POST COITAL CONTRACEPTION DYSGEUSIA 1
C POST COITAL CONTRACEPTION NAUSEA 1
C POST COITAL CONTRACEPTION PAROSMIA 1
C PRODUCT USED FOR UNKNOWN INDICATION ABORTION SPONTANEOUS 1
C RHEUMATOID ARTHRITIS INSOMNIA 1
C RHEUMATOID ARTHRITIS WEIGHT FLUCTUATION 1
C WEIGHT DECREASED BREAST TENDERNESS 1
C WEIGHT DECREASED DYSGEUSIA 1
C WEIGHT DECREASED NAUSEA 1
C WEIGHT DECREASED PAROSMIA 1
Ads by Google